Navigation Links
Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
Date:4/15/2008

fully review and consider the disclosures found in its filings which are available in the SEC EDGAR database at http://www.sec.gov and from Pharmacopeia at http://www.pharmacopeia.com. All forward-looking statements in this press release and oral statements made with respect to information contained in this press release are qualified entirely by the cautionary statements included in this press release and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by such forward-looking statements. These forward-looking statements speak only as of the date of this press release. Pharmacopeia undertakes no obligation to (and expressly disclaims any such obligation to) publicly update or revise the statements made herein or the risk factors that may relate thereto whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)
2. Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
3. Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development
4. Pharmacopeia to Present at BIO CEO & Investor Conference 2008
5. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
6. Pharmacopeia Announces Third Quarter 2007 Financial Results
7. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2008)...Dec. 1 Older adults who...flow and a greater number of small blood vessels i... at the annual meeting of the Radiological Society...onducted at the University of North Carolina ( U...scans of older adults who exercise to brain scans ...
(Date:11/28/2008)..., November 28 German biotech compa...pecialized HIV monitoring and,AIDS patient follow...ies. In,the year 2008, 2.5 million patient tests ... highly affordable "CyFlow" system, supporting alr...IDS. Due to introduction of the,Partec innovation...
(Date:11/27/2008)...ajority of acute lymphoblastic leukemia relapse ca...of diagnosis , , MEMPHIS, Tenn., Nov. 27 /P...ildren,s Research Hospital have identified distinc...en with acute lymphoblastic leukemia (ALL) that ca...ning treatments for ALL relapse in children and, u...
(Date:11/26/2008)... density, automation and intelligent clinical appl... an all new level , , CHICAGO, Ill., Nov. 2... ( www.siemens.com/healthcare ) highlights the AC...VS)(1), the world,s first multi-use, automated vo...fic Assembly and Annual Meeting of the Radiologica...
Breaking Medicine Technology:Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5AspenBio Pharma Announces 2418 Million Private Placement of Common Stock 2354 1AspenBio Pharma Announces 2418 Million Private Placement of Common Stock 2354 2AspenBio Pharma Announces 2418 Million Private Placement of Common Stock 2354 3Insect gut detects unhealthy meal 1702 1Insect gut detects unhealthy meal 1702 2QUITPLAN 28R 29 Services Can Help Minnesotans Kick Tobacco Habit for New Year 8675 1QUITPLAN 28R 29 Services Can Help Minnesotans Kick Tobacco Habit for New Year 8675 2Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights 8671 1
...A, Australia--(BUSINESS WIRE)--Mar 20, 2007 - Aust... announced highly,successful results from its Phas... novel nucleoside reverse transcriptase inhibitor,...fection in,patients with drug-resistant HIV., The ...in,reducing the viral load of patients with drug-r...
...oretic Drug Delivery System, dermal patch and a di...nephrine (IDDS), SEATTLE, March 20, 2007 /PRNews...eattle, WA, a transdermal drug delivery company,...nologies, Inc.,("TTI"), Tokyo, Japan announced t...which administers lidocaine and epinephrine,thro...
Other Medicine Technology:Avexa Reports Positive Phase IIb Result 2Avexa Reports Positive Phase IIb Result 3Avexa Reports Positive Phase IIb Result 4Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain,Associated With Insertion of an Intravenous Catheter in Their Phase,2 Clinical Trial 2Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain,Associated With Insertion of an Intravenous Catheter in Their Phase,2 Clinical Trial 3
(Date:12/1/2008)... Dec. 1 ETHICON, Inc., a Johnson ... completed the divestiture of its Professional Wou...l terms of the transaction are not being disclosed...ne Equity Partners has acquired the Professional W...dvanced wound care brands as PROMOGRAN Matrix Woun...
(Date:12/1/2008)...1 Democratic National C...lowing statement commemorating World AIDS Day on i....newscom.com/cgi-bin/prnh/20080519/DNCLOGO ) , ...DS Day, and while we have made strides, much work ...th a national and global strategy. We must focus ...
(Date:12/1/2008)...., Dec. 1 MassMutual Retirement Se...upport its increasing nonprofit business. Nonprofi...to last year. , , Dan Darby joined MassMut...or the Western region. He reports to M. Palmer Whi..., for MassMutual,s Retirement Services Division, w...
(Date:12/1/2008)..., supplements can also trigger acute organ failure...ay News) -- Antibiotics are the single largest cla...liver injury (DILI), researchers say. , The con...cute liver failure in the United States and is the...re. , DILI is caused by a wide range of prescri...
Breaking Medicine News(10 mins):Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 2Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 3Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 2Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 3Health News:Antibiotics Largest Cause of Drug-Induced Liver Damage 2
...study researchers say health professionals and pat...ectively manage the risks associated with over the... headache is one of the most common condition that...ng Over-the-Counter Medications. Some of the other...
...y started with a big bang, bringing hope and aspir...e and nature had ideas of their own. 2001 opened...and man made ones. The first internationally rep... 1st in California when a jet bound for S.F plugge...
...ave now identified a group of genes known as a gen...st cancer patients may be at high risk for having ...gene expressions in 286 tumor samples from 209 lym...were examined. The patients had not received hormo...
...n cause skin cancer – melanoma ,however researcher...ncreased, so has the number of patients surviving ...may have a beneficial influence on some kinds of c...ients who were diagnosed with melanoma in the late...
Other Medicine News:Health News:SARS (Bird Flu) spreading in the Asian continent 2
...int or DIP joint flexioncontractures of any degree... cushions injured fingers so treatment to straight...ster, more successful therapy results. Use during ...aintain gains in motion. Available in small, mediu...
...iation of the finger joints. Lined in gel padding ...ed splints can be worn at night to lessen stress o...owing injury to the PIP joint or DIP joint of the ...gament injuries. Each FingerSled Splint can be use...
FoamWrap Finger Trappers are ideal for use with custom made splints to help restore finger motion. Finger Trappers' non-slip foam lining replaces fingernail hooks and sutures to place the fingers in
One splint does it all.
Medicine Products: